81 related articles for article (PubMed ID: 16361817)
1. The prevalence of metabolic syndrome in patients with gout: a multicenter study.
Rho YH; Choi SJ; Lee YH; Ji JD; Choi KM; Baik SH; Chung SH; Kim CG; Choe JY; Lee SW; Chung WT; Song GG
J Korean Med Sci; 2005 Dec; 20(6):1029-33. PubMed ID: 16361817
[TBL] [Abstract][Full Text] [Related]
2. Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National Study.
Wang Y; Liu L; Ma S; Han J; Wang Z; Fan X; Hou X
Endocr Metab Immune Disord Drug Targets; 2024; 24(8):973-980. PubMed ID: 37702179
[TBL] [Abstract][Full Text] [Related]
3. Comorbidities in patients with crystal diseases and hyperuricemia.
Sattui SE; Singh JA; Gaffo AL
Rheum Dis Clin North Am; 2014 May; 40(2):251-78. PubMed ID: 24703346
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of incident gout in patients with hyperthyroidism: a nationwide retrospective cohort study.
Lee JY; Park SY; Sohn SY
Rheumatol Int; 2024 Mar; 44(3):451-458. PubMed ID: 37594494
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean.
Ahn JK
J Rheum Dis; 2023 Apr; 30(2):88-98. PubMed ID: 37483480
[TBL] [Abstract][Full Text] [Related]
6. Gender difference in the association between gout at diagnosis and metabolic syndrome in African population: a retrospective cohort study.
Lekpa FK; Bebey FS; Bouallo I; Njonnou SRS; Luma HN; Singwe-Ngandeu M; Choukem SP
Pan Afr Med J; 2022; 43():164. PubMed ID: 36825121
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of incident gout in young men with metabolic syndrome: A nationwide population-based cohort study of 3.5 million men.
Eun Y; Han K; Lee SW; Kim K; Kang S; Lee S; Cha HS; Koh EM; Kim H; Lee J
Front Med (Lausanne); 2022; 9():1010391. PubMed ID: 36452893
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the causal effects of blood lipid levels on gout with summary level GWAS data: two-sample Mendelian randomization and mediation analysis.
Yu X; Wang T; Huang S; Zeng P
J Hum Genet; 2021 May; 66(5):465-473. PubMed ID: 33100326
[TBL] [Abstract][Full Text] [Related]
9. Metabolic biomarkers and long-term blood pressure variability in military young male adults.
Lin YK; Liu PY; Fan CH; Tsai KZ; Lin YP; Lee JM; Lee JT; Lin GM
World J Clin Cases; 2020 Jun; 8(11):2246-2254. PubMed ID: 32548155
[TBL] [Abstract][Full Text] [Related]
10. Multimorbidity Patterns in the General Population: Results from the EpiChron Cohort Study.
Ioakeim-Skoufa I; Poblador-Plou B; Carmona-Pírez J; Díez-Manglano J; Navickas R; Gimeno-Feliu LA; González-Rubio F; Jureviciene E; Dambrauskas L; Prados-Torres A; Gimeno-Miguel A
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32545876
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China.
Zhang Y; Yang Y; Xue L; Wen J; Bo L; Tang M; Yang R; Yan D; Liu Z
BMJ Open; 2019 Aug; 9(8):e025528. PubMed ID: 31462461
[TBL] [Abstract][Full Text] [Related]
12. Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.
Chang HW; Lin YW; Lin MH; Lan YC; Wang RY
PLoS One; 2019; 14(1):e0210085. PubMed ID: 30615649
[TBL] [Abstract][Full Text] [Related]
13. Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout.
Lee KA; Ryu SR; Park SJ; Kim HR; Lee SH
Clin Rheumatol; 2018 May; 37(5):1351-1358. PubMed ID: 29288369
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015.
Kim JW; Kwak SG; Lee H; Kim SK; Choe JY; Park SH
Rheumatol Int; 2017 Sep; 37(9):1499-1506. PubMed ID: 28676911
[TBL] [Abstract][Full Text] [Related]
15. Serum apoprotein A1 levels are inversely associated with disease activity in gout: From a southern Chinese Han population.
Huang H; Yu B; Liu W; Lin Q; Chen L; Chen J; Duan L; Shi G
Medicine (Baltimore); 2017 Apr; 96(17):e6780. PubMed ID: 28445313
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome: prevalence and risk factors in Korean gout patients.
Jung JH; Song GG; Ji JD; Lee YH; Kim JH; Seo YH; Choi SJ
Korean J Intern Med; 2018 Jul; 33(4):815-822. PubMed ID: 27729624
[TBL] [Abstract][Full Text] [Related]
17. Potential of IL-33 for Preventing the Kidney Injury via Regulating the Lipid Metabolism in Gout Patients.
Duan L; Huang Y; Su Q; Lin Q; Liu W; Luo J; Yu B; He Y; Qian H; Liu Y; Chen J; Shi G
J Diabetes Res; 2016; 2016():1028401. PubMed ID: 27579324
[TBL] [Abstract][Full Text] [Related]
18. Association between serum uric acid level and metabolic syndrome components.
Nejatinamini S; Ataie-Jafari A; Qorbani M; Nikoohemat S; Kelishadi R; Asayesh H; Hosseini S
J Diabetes Metab Disord; 2015; 14():70. PubMed ID: 26380228
[TBL] [Abstract][Full Text] [Related]
19. Association between Hyperuricemia and Metabolic Syndrome: An Epidemiological Study of a Labor Force Population in Taiwan.
Wei CY; Sun CC; Wei JC; Tai HC; Sun CA; Chung CF; Chou YC; Lin PL; Yang T
Biomed Res Int; 2015; 2015():369179. PubMed ID: 26273611
[TBL] [Abstract][Full Text] [Related]
20. Global epidemiology of gout: prevalence, incidence and risk factors.
Kuo CF; Grainge MJ; Zhang W; Doherty M
Nat Rev Rheumatol; 2015 Nov; 11(11):649-62. PubMed ID: 26150127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
